Advanced Research Projects Agency for Health

United States federal agency

The Advanced Research Projects Agency for Health (ARPA-H) is an independent entity within the National Institutes of Health 22.[1] Its mission is to "make pivotal investments in break-through technologies and broadly applicable platforms, capabilities, resources, and solutions that have the potential to transform important areas of medicine and health for the benefit of all patients and that cannot readily be accomplished through traditional research or commercial activity."[2]

ARPA-H was approved by Congress with the passing of H.R.2471: Consolidated Appropriations Act, 2022 and was signed into Public Law 117-103 by U.S. president Joe Biden on March 15, 2022.[3] 15 days later Health and Human Services Secretary Xavier Becerra announced that the agency will have access to the resources of the National Institutes of Health, but will answer to the HHS Secretary.[4] The agency initially has a $1 billion budget to be used before FY2025 (Oct 2024) and the Biden Administration has requested much more funding from Congress. On September 13, 2022, Biden announced his intent to appoint Renee Wegrzyn as the agency's inaugural director, but it is still unknown where its home base will be located.[5]

History

The Defense Advanced Research Projects Agency (DARPA, formerly ARPA) has been the military's in-house innovator since 1958, a year after the USSR launched Sputnik. DARPA is widely known for creating ARPAnet, the predecessor of the internet, and has been instrumental in advancing hardened electronics, brain-computer interface technology, drones, and stealth technology. Inspired by the success of DARPA, in 2006 the Intelligence Advanced Research Projects Activity (IARPA) was created. This was followed by the Advanced Research Projects Agency–Energy (ARPA-E) in 2009. DARPA also inspired the Advanced Research and Invention Agency in the UK and recently the Biden administration has proposed ARPA-C for climate research.[6]

The Suzanne Wright Foundation proposed "HARPA" in 2017 to focus on pancreatic cancer and other challenging diseases.[7] A white paper from the Day One Project published April 19, 2020 further developed the proposal.[8] In June 2021 noted biologists Francis S. Collins (then head of the NIH), Tara Schwetz, Lawrence Tabak, and Eric Lander penned an article in Science supporting the idea.[9] Dr. Collins became an important champion of the idea on Capitol Hill and the legislation garnered numerous sponsors in the 117th Congress.

In September 2022, Renee Wegrzyn was appointed as the agency's inaugural director.[10][11][12]

Research

A White House white paper identifies a number of potential directions for technological development that could occur under the direction of ARPA-H, including cancer vaccines, pandemic preparedness, and prevention technologies, less intrusive wearable blood glucose monitors, and patient-specific T-cell therapies.[13] Additionally, the proposal suggests that ARPA-H focus on platforms to reduce health disparities in maternal morbidity and mortality and improve how medications provided are taken.

References

  1. ^ "Russell Named Acting Deputy Director for New Advanced Research Entity". NIH Record. 2022-06-10. Retrieved 2022-08-28.
  2. ^ "ARPA-H Mission". National Institutes of Health (NIH). 29 June 2021. Retrieved 27 April 2022.
  3. ^ Jeffries, Hakeem S. (15 March 2022). "H.R.2471 - 117th Congress (2021-2022): Consolidated Appropriations Act, 2022". www.congress.gov. Retrieved 27 April 2022.
  4. ^ Mesa, Natalie (1 April 2022). "ARPA-H to Be Within NIH but Independently Managed by HHS". The Scientist Magazine. Retrieved 27 April 2022.
  5. ^ Kozlov, Max (13 September 2022). "Billion-dollar US health agency gets new chief — but its direction remains in limbo". Nature. Retrieved 14 September 2022.
  6. ^ Tollefson, Jeff (22 July 2021). "The rise of 'ARPA-everything' and what it means for science". Nature. 595 (7868): 483–484. Bibcode:2021Natur.595..483T. doi:10.1038/d41586-021-01878-z. PMID 34244687. S2CID 235787224. Retrieved 27 April 2022.
  7. ^ "HARPA: Health Advanced Research Projects Agency". The Suzanne Wright Foundation. Retrieved 27 April 2022.
  8. ^ Stebbins, Michael; Ling, Geoffrey (19 April 2020). "Creating the Health Advanced Research Projects Agency (HARPA)". Retrieved 27 April 2022. {{cite journal}}: Cite journal requires |journal= (help)
  9. ^ Collins, Francis S.; Schwetz, Tara A.; Tabak, Lawrence A.; Lander, Eric S. (9 July 2021). "ARPA-H: Accelerating biomedical breakthroughs". Science. 373 (6551): 165–167. Bibcode:2021Sci...373..165C. doi:10.1126/science.abj8547. PMID 34244402. S2CID 235769725.
  10. ^ "President Biden Announces Intent to Appoint Dr. Renee Wegrzyn as Inaugural Director of Advanced Research Projects Agency for Health (ARPA-H)". The White House. 2022-09-12. Retrieved 2022-09-12.
  11. ^ "DARPA Forward | Dr. Renee Wegrzyn". forward.darpa.mil. Retrieved 2022-09-12.
  12. ^ "Biden's new biomedical innovation agency gets its first director". www.science.org. 2022-09-12. doi:10.1126/science.ade8505. Retrieved 2022-09-18.
  13. ^ "ARPA-H Frequently Asked Questions" (PDF). The White House. Retrieved 27 April 2022.

External links

  • Official website
  • v
  • t
  • e
Institutes
CentersPrograms
DirectorsRelated
Italics indicate acting officeholders
  • v
  • t
  • e
Federal research and development agencies of the United States (list)
Independent
agencies
Agriculture
Commerce
Defense
Army
Marine Corps
Navy
Air Force
Space Force
Other
Education
Energy
Health and
Human Services
Homeland Security
Interior
Justice
Transportation
Treasury
Veterans Affairs
Executive Office
of the President
Legislative branch
Judicial branch